-
global centre for vaccine discovery, development and manufacture. Its research underpinned the development of the ChAdOx-1 nCoV-19 vaccine, subsequently licensed to AstraZeneca, with benefit to over 180
-
including Heptares Therapeutics and Galapagos NV, as well as consolidating links to the pharmaceutical giant AstraZeneca, resulting in enhanced funding and joint publications. By linking small molecule
Searches related to master
Enter an email to receive alerts for master "AstraZeneca" positions